Figure 3.
Immunohistochemical analysis of ERGIC3 in various tumor tissues using 6-C4. (a) non-small cell lung cancer (NSCLC); (b) pancreatic carcinoma; (c) hepatocellular carcinoma (HCC); (d) esophagus carcinoma; (e) gastric carcinoma; (f) colon carcinoma; (g) renal cell carcinoma; (h) bladder carcinoma; (i) mammary carcinoma; (j) cervical carcinoma; (k) prostate carcinoma; (l) thyroid carcinoma; (m) osteosarcoma; (n) chondrosarcoma; (o) fibrosarcoma.